Liquid Structure™ Technology
Research Team

MARK J. ROSENFELD, M.S., Ph.D

Chief Executive Officer & Chief Science Officer, Ananda Scientific

  • US Scientist, Joint United Nations FAO/IAEA Committee on Transboundary Diseases (innovated a device for the molecular detection of bird flu and other influenzas)

  • Visiting Scholar, Giant Panda Conservation and Research Center, Peking University, China

  • Faculty, Molecular Biology, University of Utah School of Medicine

  • Consultant, Cannabis Legalization and Regulatory Affairs to Multiple States

NISSIM GARTI, M.S., Ph.D.

Scientific & Technical Research Partner, Ananda Scientific

  • Director, Casali Institute of Applied Chemistry, The Hebrew University of Jerusalem

  • Search Committee, 2013 Nobel Prize in Chemistry

  • Recipient 2016 Herjie Award (global award for nanotechnology research excellence)

  • The Japanese Award for the Promotion of Senior Foreign Scientists

  • Ratner Chair of Chemistry of the Hebrew University
Facebook Twitter Dribbble Behance

PERRY G. FINE, M.D.

Medical Director, Ananda Scientific

  • President Emeritus, American Academy of Pain Medicine

  • Member, FDA Advisory Board for Opioids

  • Chair, National Initiative on Pain Control

  • Board of Directors, American Academy of Pain Medicine

  • Board of Directors, American Pain Foundation

  • Consultant, Cannabis Legalization and Regulatory Affairs to Multiple States

Jacobi (Kobi) Atsmon, M.D.

Clinical Trials Director, Ananda Scientific

  • Managing Director, Early Phase Clinical Trials, Clinical Research Center (CRC), Tel Aviv Sourasky Medical Center, Israel

  • Principal Investigator for over 300 clinical studies and considered one of the leading experts in Israel on early phase clinical trials

  • Senior Lecturer, Tel Aviv University School of Medicine

SUSAN ALPERT, M.D., Ph.D.

Regulatory Affairs & Clinical Trials Advisor, Ananda Scientific

  • Director, USFDA Office of Device Evaluation

  • Senior Vice President − Global Regulatory Affairs, Medtronic

  • Vice President − Regulatory Sciences, C.R. Baird, Inc.

  • Chairman, Regulatory Affairs Professionals Society

  • Advisory Board, Medical Technology Leadership Forum

  • Executive Committee, Clinical Trials Transformation Initiative

MARK M. COHEN, MBBS (Hons), PhD, FAMAC, FICAE

Wellness & Sports Medicine, Ananda Scientific

  • Chairman, Wellness Program,, Royal Melbourne Institute of Technology (RMIT University), Australia

  • Director, Centre for Complementary Medicine, Institute for Health Services Research, Monash University, Australia

  • Expert Advisor, Australia Therapeutics Good Authority Complementary Medicine Evaluation Committee

Michael Dor MD, MPA

Medical Advisor – Cannabinoids, Ananda Scientific

  • Medical Director, Medical Cannabis Unit, Israel Health Ministry

  • Recipient, Presidential Award (highest Israel civilian honor)

  • Head, Hospitals Division, Israel Health Ministry

  • Head, General Medicine Division, Israel Health Ministry

  • Deputy Director, Health Management, Israel Health Ministry

Silviu Brill, MD

Phase 2 Clinical Director – Neuropathic Pain, Ananda Scientific

  • Director, Pain Center, Tel Aviv Sourasky Medical Center

  • Professor, Faculty of Medicine, Ben Gurion University

  • President Emeritus, Israel Pain Association

  • President Emeritus, Pain Section, Israel Society of Anesthesiology

  • Member, European Pain Federation Task Force on Cannabis Based Medicine

DAVID E. MOODY, PhD

Cannabinoid Analytics – Bioassays, Ananda Scientific

  • Chairman, Pharmacology and Toxicology Department, School of Pharmacy, University of Utah

  • Inspector. National Laboratory Certification Program

  • Developed and implemented the cannabinoid tests for bodily fluids used by the USFDA, US Drug Enforcement Agency and National Institute of Drug Abuse

  • Grant Reviewer, Neuropharmacology, NIH Center for Review